Christopher Swift - 17 Mar 2025 Form 4 Insider Report for HARTFORD INSURANCE GROUP, INC. (HIG)

Role
Chairman and CEO, Director
Signature
Anthony J. Salerno, Jr., Attorney-in-Fact
Issuer symbol
HIG
Transactions as of
17 Mar 2025
Net transactions value
-$7,531,024
Form type
4
Filing time
19 Mar 2025, 16:07:39 UTC
Previous filing
06 Mar 2025
Next filing
04 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIG Common Stock Options Exercise $4,274,479 +98,061 +46% $43.59 309,143 17 Mar 2025 Direct
transaction HIG Common Stock Sale $60,505 -500 -0.16% $121.01 308,643 17 Mar 2025 Direct F1
transaction HIG Common Stock Sale $11,744,998 -97,561 -32% $120.39 211,082 17 Mar 2025 Direct F1, F2
holding HIG Common Stock 40,003 17 Mar 2025 By Spouse
holding HIG Common Stock 95,386 17 Mar 2025 Swift Family Gift Trust
holding HIG Common Stock 60,865 17 Mar 2025 Swift Family Legacy Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIG Stock Option Options Exercise $0 -98,061 -33% $0.000000 196,320 17 Mar 2025 Common Stock 98,061 $43.59 Direct F3
holding HIG Stock Option 302,908 17 Mar 2025 Common Stock 302,908 $48.89 Direct F4
holding HIG Stock Option 352,263 17 Mar 2025 Common Stock 352,263 $49.01 Direct F5
holding HIG Stock Option 310,820 17 Mar 2025 Common Stock 310,820 $51.87 Direct F6
holding HIG Stock Option 284,819 17 Mar 2025 Common Stock 284,819 $53.81 Direct F7
holding HIG Stock Option 327,679 17 Mar 2025 Common Stock 327,679 $55.27 Direct F8
holding HIG Stock Option 301,932 17 Mar 2025 Common Stock 301,932 $69.41 Direct F9
holding HIG Stock Option 248,933 17 Mar 2025 Common Stock 248,933 $78.28 Direct F10
holding HIG Stock Option 116,414 17 Mar 2025 Common Stock 116,414 $95.74 Direct F11
holding HIG Stock Option 99,403 17 Mar 2025 Common Stock 99,403 $116.41 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 4, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2016 and are scheduled to expire on March 1, 2026.
F2 Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $120.00 - $120.99 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The options became fully exercisable on March 1, 2019, the third anniversary of the grant date.
F4 The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
F5 The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F6 The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F7 The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F8 The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F9 The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F10 One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F11 One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F12 One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.